BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3752938)

  • 1. Pleiotropic drug resistance, protein overexpression, and cytogenetic signs of gene amplification in mouse tumor cells.
    Dahllöf B; Martinsson T; Levan G
    Anticancer Res; 1986; 6(4):579-81. PubMed ID: 3752938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69AR human tumor cell lines.
    Slovak ML; Ho JP; Bhardwaj G; Kurz EU; Deeley RG; Cole SP
    Cancer Res; 1993 Jul; 53(14):3221-5. PubMed ID: 8391919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug resistance in Chinese hamster lung and mouse tumor cells.
    Biedler JL; Chang TD; Meyers MB; Peterson RH; Spengler BA
    Cancer Treat Rep; 1983 Oct; 67(10):859-67. PubMed ID: 6354433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic study of stable inheritable cell resistance to colchicine. Chromosomal and hybridization analysis].
    Kopnin BP
    Genetika; 1982 Oct; 18(10):1693-702. PubMed ID: 6890923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The semistability of centric chromatin bodies during long-term passage of multidrug resistant mouse-Chinese hamster cell hybrids.
    Jakobsson AH
    Anticancer Res; 1988; 8(3):307-12. PubMed ID: 3389736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16: evidence that chromosome breakage plays a key role in MRP or LRP gene amplification.
    Slovak ML; Ho JP; Cole SP; Deeley RG; Greenberger L; de Vries EG; Broxterman HJ; Scheffer GL; Scheper RJ
    Cancer Res; 1995 Oct; 55(19):4214-9. PubMed ID: 7671223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of two cytogenetic forms of amplified DNA: evidence for a role in tumor growth in an intraspecific mouse hybrid cell line.
    Wigley CB; Cowell JK
    J Natl Cancer Inst; 1984 Jul; 73(1):219-26. PubMed ID: 6588226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic evidence for gene amplification in mouse skin carcinogenesis.
    Aldaz CM; Conti CJ; O'Connell J; Yuspa SH; Klein-Szanto AJ; Slaga TJ
    Cancer Res; 1986 Jul; 46(7):3565-8. PubMed ID: 3708588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Loss and stabilization of aminopterin resistance in murine cell lines].
    Safronov VV; Kapitsa OS; Sapegina MB; Gorodetskiĭ SI
    Genetika; 1985 Dec; 21(12):1974-82. PubMed ID: 3866726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene amplification in human tumor cells.
    Arrighi FE
    Prog Clin Biol Res; 1983; 132C():259-68. PubMed ID: 6634775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular/cytogenetic alterations accompanying the development of multidrug resistance in the J774.2 murine cell line.
    Slovak ML; Lothstein L; Horwitz SB; Trent JM
    Leukemia; 1988 Jul; 2(7):453-8. PubMed ID: 2899184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification.
    Shuster MI; Han L; Le Beau MM; Davis E; Sawicki M; Lese CM; Park NH; Colicelli J; Gollin SM
    Genes Chromosomes Cancer; 2000 Jun; 28(2):153-63. PubMed ID: 10825000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amplification of portions of the genome in mammalian somatic cells resistant to colchicine. II. Marker chromosomes with long homogeneously staining regions in colchicine-resistant cells of the Djungarian hamster].
    Kopnin BP; Godkov AV
    Genetika; 1982 Sep; 18(9):1513-23. PubMed ID: 6183166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relation of mammalian cell resistance to actinomycin D with a change in the karyotype and a decrease in cytoplasmic membrane permeability].
    Massino IuS; Kakpakova ES; Kopnin BP; Pogosiants EE
    Genetika; 1981; 17(7):1253-8. PubMed ID: 7196855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleiotropic drug resistance and gene amplification in a SEWA mouse tumor cell line. Complex relations revealed by drug uptake data, and lipid and protein analysis.
    Martinsson T; Dahllöf B; Wettergren Y; Leffler H; Levan G
    Exp Cell Res; 1985 Jun; 158(2):382-94. PubMed ID: 4007061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification of 4q21-q22 and the MXR gene in independently derived mitoxantrone-resistant cell lines.
    Knutsen T; Rao VK; Ried T; Mickley L; Schneider E; Miyake K; Ghadimi BM; Padilla-Nash H; Pack S; Greenberger L; Cowan K; Dean M; Fojo T; Bates S
    Genes Chromosomes Cancer; 2000 Jan; 27(1):110-6. PubMed ID: 10564593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene amplification and drug resistance in mammalian cells.
    Schimke RT; Brown PC; Kaufman RJ
    Natl Cancer Inst Monogr; 1982; 60():79-86. PubMed ID: 7121575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Amplification of portions of the genome in mammalian somatic cells resistant to colchicine. I. Chromosome 4 trisomy in the development of gene amplification and colchicine resistance in Djungarian hamster cells].
    Kopnin BP
    Genetika; 1982 Sep; 18(9):1503-12. PubMed ID: 6890494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes associated with the development of resistance to imatinib (STI571) in two leukemia cell lines expressing p210 Bcr/Abl protein.
    Scappini B; Gatto S; Onida F; Ricci C; Divoky V; Wierda WG; Andreeff M; Dong L; Hayes K; Verstovsek S; Kantarjian HM; Beran M
    Cancer; 2004 Apr; 100(7):1459-71. PubMed ID: 15042680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells.
    Slapak CA; Fracasso PM; Martell RL; Toppmeyer DL; Lecerf JM; Levy SB
    Cancer Res; 1994 Nov; 54(21):5607-13. PubMed ID: 7923205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.